Measles and rubella monitoring, February 2013
Measles and rubella are targeted for elimination in Europe by 2015. ECDC closely monitors progress towards interruption of endemic transmission of both diseases through enhanced surveillance and epidemic intelligence. Measles and rubella vaccinations are routinely delivered as trivalent measles-mumps-rubella (MMR) vaccine in Europe, and the first of the two recommended doses is normally given during the second year of life.
8 230 cases of measles were reported in EU/EEA countries in 2012, and rubella cases numbered 27 276. Whilst the number of measles cases is significantly lower than 2011 and 2010 it still continues to exceed the measles elimination target rate of less than one case per million people. The number of rubella cases, on the other hand, has jumped up from the 3 442 cases in the previous year.
This month’s Measles and Rubella monitoring report from ECDC reports on the latest surveillance data drawn from The European Surveillance System and carries analysis on the January to December 2012 period.
Measles cases are unsurprisingly low
The previous two years in EU/EEA countries have had around 30 000 reported cases of measles but in 2012 this number is down to 8 230. Four countries, France, Italy, Romania, Spain and the United Kingdom, accounted for 94% of the cases. This drop in measles cases, to pre-outbreak levels, is expected after a large scale outbreak where many of those previously susceptible have developed natural immunity as a result of the disease or supplementary vaccination activities.
Although it is good to see the number of cases in 2012 back to pre-outbreak levels, only twelve countries met the elimination target of less than one case of measles per million population during the last 12 months.
The 26 EU/EEA countries contributing to enhanced rubella surveillance reported 27 276 cases during the last 12-month period (January to December 2012). A number of countries have not reported data for December (and other months); including Romania, which accounts for 76% of all rubella cases for 2012. The outbreak in Poland accounts for a further 23% of cases.
Seasonal influenza - Annual Epidemiological Report for 2019–2020
6 Aug 2020 - Influenza activity started in week 45/2019 and returned to baseline levels in week 13/2020, earlier than previous seasons. Influenza viruses circulated at high levels between weeks 52/2019 and 10/2020 (based on increased proportions (40% and above) of sentinel specimens testing positive for influenza viruses). This is comparable to previous seasons.
Influenza virus characterisation - Summary Europe, June 2020
23 Jul 2020 - This is the eighth report for the 2019–20 influenza season. As of week 25/2020, 164 883 influenza detections across the WHO European Region had been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 479 (98%) of 4 568 ascribed to a lineage being B/Victoria.
Hepatitis B - Annual Epidemiological Report for 2018
22 Jul 2020 - For 2018, 30 EU/EEA Member States reported 24 588 cases of hepatitis B virus (HBV) infection. When the five countries that only reported acute cases are excluded, the number of cases is 24 034, which corresponds to a crude rate of 6.0 cases per 100 000 population.